All Stories

  1. Preoperative paroxysmal atrial fibrillation predicts high cardiovascular mortality in patients undergoing surgical aortic valve replacement with a bioprosthesis: CAREAVR study
  2. Metastable Atrial State Underlies the Primary Genetic Substrate for MYL4 Mutation-Associated Atrial Fibrillation
  3. CONTEMPORARY RADIATION DOSES IN INTERVENTIONAL CARDIOLOGY: A NATIONWIDE STUDY OF PATIENT SKIN DOSES IN FINLAND
  4. Etiology of Minor Troponin Elevations in Patients with Atrial Fibrillation at Emergency Department–Tropo-AF Study
  5. Population trends in aortic valve surgery in Finland between 2001 and 2016
  6. Evolving Field of Long-term Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation
  7. Assessment of myocardial viability with [15O]water PET: A validation study in experimental myocardial infarction
  8. Distribution of ischemic strokes in patients with atrial fibrillation
  9. Clinical assessment of a non-invasive wearable MEMS pressure sensor array for monitoring of arterial pulse waveform, heart rate and detection of atrial fibrillation
  10. CONTEMPORARY RADIATION DOSES IN INTERVENTIONAL CARDIOLOGY: A NATIONWIDE STUDY OF PATIENT DOSES IN FINLAND
  11. Reliability of Self-Applied Smartphone Mechanocardiography for Atrial Fibrillation Detection
  12. Machine Learning Based Classification of Myocardial Infarction Conditions Using Smartphone-Derived Seismo- and Gyrocardiography
  13. Preoperative myocardial troponin T elevation is associated with the fracture type in patients with proximal femoral fracture
  14. Occurrence of Postpericardiotomy Syndrome: Association With Operation Type and Postoperative Mortality After Open‐Heart Operations
  15. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
  16. Cardioversion for atrial fibrillation – how to prevent thromboembolic complications?
  17. Meta-analysis of the Sources of Bleeding after Adult Cardiac Surgery
  18. P5338The occurrence of postpericardiotomy syndrome: association with operation type and post-operative mortality after open-heart operations
  19. P1655Preoperative predictors for systemic inflammatory response in open-heart surgery
  20. Traumatic and spontaneous intracranial hemorrhage in atrial fibrillation patients on warfarin
  21. Optimal timing for cardioversion in patients with atrial fibrillation
  22. Performance of CHA2DS2-VASc score for stroke prediction after surgical aortic valve replacement
  23. Multiclass Classifier based Cardiovascular Condition Detection Using Smartphone Mechanocardiography
  24. How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?
  25. Usefulness of the CHA 2 DS 2 -VASc and HAS-BLED Scores in Predicting the Risk of Stroke Versus Intracranial Bleeding in Patients With Atrial Fibrillation (from the FibStroke Study)
  26. Impact of preoperative thrombocytopenia on the outcome after coronary artery bypass grafting
  27. Mobile Phone Detection of Atrial Fibrillation With Mechanocardiography
  28. Determinants of re-operation for bleeding in head and neck cancer surgery
  29. CHA2DS2-VASC AND HAS-BLED SCORES IN PREDICTING THE RISK OF STROKE VERSUS INTRACRANIAL BLEED: THE FIBSTROKE STUDY
  30. MOBILE PHONE DETECTION OF ATRIAL FIBRILLATION: THE MODE-AF STUDY
  31. PERFORMANCE OF CHA2DS2-VASC SCORE IN STROKE PREDICTION IN PATIENTS UNDERGOING SURGICAL AORTIC VALVE REPLACEMENT WITH BIOPROSTHESIS
  32. Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry
  33. Thromboembolisms related to post-operative electrical cardioversions for atrial fibrillation in patients with surgical aortic valve replacement
  34. Atrial Fibrillation Detection via Accelerometer and Gyroscope of a Smartphone
  35. Comprehensive Analysis of Cardiogenic Vibrations for Automated Detection of Atrial Fibrillation Using Smartphone Mechanocardiograms
  36. Occurrence and Classification of Cerebrovascular Events after Isolated Bioprosthetic Surgical Aortic Valve Replacement: A Competing Risk Analysis of the CAREAVR Study
  37. Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry
  38. Population trends in mitral valve surgery in Finland between 1997 and 2014: the finnish CVD register
  39. Clinical manifestations and outcomes of severe warfarin overanticoagulation: from the EWA study
  40. Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
  41. Transfusion and blood stream infections after coronary surgery
  42. Automated Detection of Atrial Fibrillation Based on Time–Frequency Analysis of Seismocardiograms
  43. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
  44. Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation
  45. Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry
  46. Imaging of αvβ3 integrin expression in experimental myocardial ischemia with [68Ga]NODAGA-RGD positron emission tomography
  47. Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation—The EWA study
  48. Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk
  49. Prediction of ineffective elective cardioversion of atrial fibrillation: a retrospective multi-center patient cohort study
  50. Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry
  51. Comparison of two different sampling intervals for optical coherence tomography evaluation of neointimal healing response after coronary stent implantation
  52. Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation — The FibStroke study
  53. A smartphone-only solution for detecting indications of acute myocardial infarction
  54. Stroke as the First Manifestation of Atrial Fibrillation
  55. Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial Infarction
  56. Trends in rates, patient selection and prognosis of coronary revascularisations in Finland between 1994 and 2013: the CVDR
  57. Permanent work disability in patients ≤50 years old after percutaneous coronary intervention and coronary artery bypass grafting (the CRAGS study)
  58. Detection of atrial fibrillation with seismocardiography
  59. Incidence and predictors of 30-day cardiovascular complications in patients undergoing head and neck cancer surgery
  60. Excessive intravenous fluid therapy in head and neck cancer surgery
  61. Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study
  62. Early vascular healing after titanium–nitride–oxide-coated stent versus platinum–chromium everolimus-eluting stent implantation in patients with acute coronary syndrome
  63. Predicting the outcome of hip fracture patients by using N-terminal fragment of pro-B-type natriuretic peptide
  64. Strokes after cardioversion of atrial fibrillation — The FibStroke study
  65. Occurrence of postpericardiotomy syndrome admissions: A population-based registry study
  66. Automatic detection of atrial fibrillation using MEMS accelerometer
  67. Underuse of anticoagulation in stroke patients with atrial fibrillation - the FibStroke Study
  68. Outcome after coronary artery bypass grafting and percutaneous coronary intervention in patients with stage 3b–5 chronic kidney disease
  69. Predictors of permanent work disability among ≤50-year-old patients undergoing percutaneous coronary intervention
  70. Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial
  71. Ventricular rate during acute atrial fibrillation and outcome of electrical cardioversion: The FinCV Study
  72. Incidence and risk factors of postpericardiotomy syndrome requiring medical attention: The Finland postpericardiotomy syndrome study
  73. Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: The AFCAS study
  74. Aberrant Circulating Levels of Purinergic Signaling Markers Are Associated With Several Key Aspects of Peripheral Atherosclerosis and ThrombosisNovelty and Significance
  75. Early Neointimal Coverage and Vasodilator Response Following Biodegradable Polymer Sirolimus-Eluting vs. Durable Polymer Zotarolimus-Eluting Stents in Patients With Acute Coronary Syndrome
  76. European Congress on e-Cardiology & e-Health October 2014, Selected Abstracts
  77. Prognosis and disease progression in patients under 50 years old undergoing PCI: The CRAGS (Coronary aRtery diseAse in younG adultS) study
  78. Comparison of 30-Day and 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients Aged ≤50 Years (the Coronary aRtery diseAse in younG adultS Study)
  79. Usefulness of Troponin T to Predict Short-Term and Long-Term Mortality in Patients After Hip Fracture
  80. Performance of Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
  81. Outcome after coronary artery bypass surgery and percutaneous coronary intervention in patients with atrial fibrillation and oral anticoagulation
  82. Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry
  83. Transthoracic echocardiography for non-invasive assessment of coronary vasodilator function after DES implantation
  84. Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy
  85. CHADS 2 , CHA 2 DS 2 -VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention
  86. CLINICAL OUTCOME OF PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH BARE-METAL VERSUS DRUG-ELUTING STENTS: INSIGHTS FROM THE AFCAS REGISTRY
  87. IMPACT OF ANEMIA ON CLINICAL OUTCOME IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE AFCAS REGISTRY
  88. One-Year Outcome of Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting: An Analysis of the AFCAS Registry
  89. Bare-Metal vs. Drug-Eluting Stents in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
  90. Erratum to: Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial
  91. Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial
  92. Thrombocytopenia in Patients With Atrial Fibrillation on Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
  93. Comparison of Additional Versus No Additional Heparin During Therapeutic Oral Anticoagulation in Patients Undergoing Percutaneous Coronary Intervention
  94. Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes
  95. Impaired ATP-Induced Coronary Blood Flow and Diminished Aortic NTPDase Activity Precede Lesion Formation in Apolipoprotein E–Deficient Mice
  96. Cold Pressor Test Safety—The Incidence of Vasovagal Reactions
  97. Decreased endothelin-1 levels after acute consumption of red wine and de-alcoholized red wine
  98. Cardiopulmonary involvement in Fabry’s disease
  99. Cardiac magnetic resonance imaging in valvular heart disease
  100. Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance
  101. High dose of red wine elicits enhanced inhibition of fibrinolysis
  102. Effects of cognac on coronary flow reserve and plasma antioxidant status in healthy young men
  103. Assessment of coronary blood flow and the reactivity of the microcirculation non-invasively with transthoracic echocardiography
  104. A moderate dose of red wine, but not de-alcoholized red wine increases coronary flow reserve
  105. Vasodilation of Epicardial Coronary Artery can be Measured with Transthoracic Echocardiography
  106. Determinants of coronary flow velocity reserve in healthy young men
  107. Comparison of MRI and positron emission tomography for measuring myocardial perfusion reserve in healthy humans
  108. Coronary artery diameter can be assessed reliably with transthoracic echocardiography